Volume 128, Issue 7, Pages (June 2005)

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease Stephan R. Targan, Carol J. Landers,
Volume 117, Issue 4, Pages (October 1999)
Volume 118, Issue 6, Pages (June 2000)
Volume 127, Issue 4, Pages (October 2004)
Volume 135, Issue 5, Pages (November 2008)
Volume 126, Issue 1, Pages (January 2004)
Volume 145, Issue 4, Pages e2 (October 2013)
Volume 132, Issue 7, Pages (June 2007)
Covering the Cover Gastroenterology
Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy  Jean–François Rahier, Sébastien.
Volume 118, Issue 6, Pages (June 2000)
Volume 133, Issue 5, Pages (November 2007)
Volume 133, Issue 1, Pages (July 2007)
Volume 149, Issue 2, Pages e3 (August 2015)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 154, Issue 1, Pages e6 (January 2018)
Volume 130, Issue 4, Pages (April 2006)
David J. Brenner, Eric J. Hall, Rochelle E. Curtis, Elaine Ron 
Gastroenterology 2011–2016: Looking Back and Forward
Volume 129, Issue 6, Pages (December 2005)
Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease
Volume 155, Issue 4, Pages (October 2018)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Khursheed N. Jeejeebhoy  Gastroenterology 
Volume 127, Issue 4, Pages (October 2004)
Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§ 
Volume 137, Issue 2, Pages (August 2009)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 130, Issue 2, Pages (February 2006)
Severe Constipation Clinical Gastroenterology and Hepatology
Ronnie Fass, Stephen J. Sontag, Barry Traxler, Mark Sostek 
Volume 148, Issue 5, Pages (May 2015)
Protein-Losing Enteropathy in Crohn’s Disease
Volume 142, Issue 1, Pages e5 (January 2012)
Volume 132, Issue 1, Pages (January 2007)
Barry Marshall 2005 Nobel Laureate in Medicine and Physiology
Volume 136, Issue 7, Pages (June 2009)
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
Antoine Debourdeau, Anne Bozon, Romain Altwegg  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Volume 121, Issue 5, Pages (November 2001)
Volume 150, Issue 7, Pages (June 2016)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials  Edward.
The Dawning of a New Editorial Board for Gastroenterology
Volume 135, Issue 2, Pages (August 2008)
A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease  Vered Abitbol,
Volume 119, Issue 4, Pages (October 2000)
Volume 121, Issue 5, Pages (November 2001)
Volume 156, Issue 4, Pages (March 2019)
Volume 126, Issue 1, Pages (January 2004)
Volume 127, Issue 5, Pages (November 2004)
Volume 156, Issue 4, Pages (March 2019)
Volume 117, Issue 3, Pages (September 1999)
An Unusual Cause of Perianal Ulceration in an HIV-Negative Patient
Liver Transplantation for Hepatocellular Carcinoma
Michelle Maria Pietzak  Gastroenterology 
Volume 127, Issue 4, Pages (October 2004)
Volume 153, Issue 3, Pages e2 (September 2017)
Volume 128, Issue 4, Pages (April 2005)
Medical Therapy for Refractory Pediatric Crohn’s Disease
Volume 126, Issue 7, Pages (June 2004)
Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.
Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.
Presentation transcript:

Volume 128, Issue 7, Pages 1812-1818 (June 2005) A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine  Marc Lémann, Jean-Yves Mary, Jean-Frédéric Colombel, Bernard Duclos, Jean-Claude Soule, Eric Lerebours, Robert Modigliani, Yoram Bouhnik  Gastroenterology  Volume 128, Issue 7, Pages 1812-1818 (June 2005) DOI: 10.1053/j.gastro.2005.03.031 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Trial profile. Gastroenterology 2005 128, 1812-1818DOI: (10.1053/j.gastro.2005.03.031) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Time-to-relapse curves according to treatment group. Gastroenterology 2005 128, 1812-1818DOI: (10.1053/j.gastro.2005.03.031) Copyright © 2005 American Gastroenterological Association Terms and Conditions